Managing Raynaud's phenomenon.
- 12 July 1986
- Vol. 293 (6539) , 88-89
- https://doi.org/10.1136/bmj.293.6539.88
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- TREATMENT OF CHILDHOOD RAYNAUD'S DISEASE BY TRANSDERMAL PROSTAGLANDIN E2 ANALOGUEThe Lancet, 1985
- Treatment of Raynaud's phenomenon with calcium channel blockersThe American Journal of Medicine, 1985
- Prostaglandin E1 vasospastic disease and thermography.Annals of the Rheumatic Diseases, 1985
- Behavioral treatment of Raynaud's disease: Long-term follow-up.Journal of Consulting and Clinical Psychology, 1985
- Effect of dazoxiben, a thromboxane synthetase inhibitor on skin‐blood flow following cold challenge in patients with Raynaud's phenomenonEuropean Journal of Clinical Investigation, 1985
- Behavioral treatment of Raynaud's disease: Long-term follow-up.Journal of Consulting and Clinical Psychology, 1985
- Treatment of Raynaud's phenomenon with ketanserin in patients with connective tissue disorders.BMJ, 1984
- Blood Viscosity, Finger Systolic Pressure and Effect of Dazoxiben Treatment in Primary Vasospastic DiseaseUpsala Journal of Medical Sciences, 1984
- INTERMITTENT EPOPROSTENOL (PROSTACYCLIN) INFUSION IN PATIENTS WITH RAYNAUD'S SYNDROMEThe Lancet, 1983
- The Treatment of Severe Raynaud's Phenomenon with VerapamilThe Journal of Clinical Pharmacology, 1982